Peer Review History
| Original SubmissionJune 13, 2025 |
|---|
|
Dear Dr. Barba Sánchez, Please submit your revised manuscript by Aug 23 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols . We look forward to receiving your revised manuscript. Kind regards, Sylvester Chidi Chima, M.D., L.L.M, LLD Academic Editor PLOS ONE Journal requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. Thank you for uploading your study's underlying data set. Unfortunately, the repository you have noted in your Data Availability statement does not qualify as an acceptable data repository according to PLOS's standards. At this time, please upload the minimal data set necessary to replicate your study's findings to a stable, public repository (such as figshare or Dryad) and provide us with the relevant URLs, DOIs, or accession numbers that may be used to access these data. For a list of recommended repositories and additional information on PLOS standards for data deposition, please see https://journals.plos.org/plosone/s/recommended-repositories . 3. Please include a separate caption for each figure in your manuscript. Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? Reviewer #1: Yes Reviewer #2: Partly ********** 2. Has the statistical analysis been performed appropriately and rigorously? -->?> Reviewer #1: Yes Reviewer #2: N/A ********** 3. Have the authors made all data underlying the findings in their manuscript fully available??> The PLOS Data policy Reviewer #1: Yes Reviewer #2: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English??> Reviewer #1: Yes Reviewer #2: Yes ********** Reviewer #1: This is a well-written manuscript on an important aspect. I have a few comments. Authors need to describe the analysis process in more detail. For example, the manuscript currently states that ‘The lexical, grammatical, and textual dimensions of the discourse formulation of each parliamentary group were considered’. What did this process involve? Author contributions state that PGR conducted the analysis and interpretation of the data together with EG. What did data analysis and interpretation involve? Were there any discrepancies or disagreements? If so, how were these resolved? Methods also state –‘Additionally, elements impacting processes of stigmatization of people living with HIV and sexual minorities were considered.’ What did this involve? How did authors arrive at the themes for example? Discussion needs to include a strengths and limitations section/paragraph. For example, one limitation could be that the results are informed by a relatively small number of initiatives 36/40,644. In addition authors could include a positionality/reflexivity statement. Minor issues initiatives in in this context (delete 2nd “in”) seeking to position them against…[them]? Methods heading in body of paper should be ‘Materials and Methods Mixed-method(s)? Just wondering if there is any way of referencing the quotes. Include a space before references – e.g., us [1] Reviewer #2: I have carefully reviewed the manuscript entitled “From Fear of Infection to Awareness Against Stigma: A Mixed-Methods Analysis of Discourses on HIV in Parliamentary Contexts.” The study addresses a timely and significant topic, particularly in light of the ongoing stigmatization of HIV and the relatively limited research on the role of legislative discourse in shaping public health narratives. While the manuscript demonstrates originality and relevance, there are several aspects that require further development and clarification. Therefore, I recommend that the authors undertake substantial revisions to enhance the overall quality and rigor of the work prior to its consideration for publication. My comments are as follows: 1) The manuscript would benefit from a dedicated literature review section, distinct from the introduction, to provide a more comprehensive overview of recent and relevant scholarly work. A separate literature review should incorporate the most up-to-date research related to the intersection of political ideology and public health, particularly in the context of HIV. Moreover, the authors should offer a more explicit discussion of their study's contribution. While they state that, to their knowledge, no prior research has examined the relationship between parliamentary discourses on HIV and political ideologies, this claim requires substantiation—such as evidence of a systematic literature search. The identification and articulation of the research gap should be strengthened through engagement with similar studies, not only in HIV but also in broader analyses of how political ideologies influence health outcomes or other issues. Referencing relevant comparative studies from other national or regional contexts would further reinforce the manuscript’s originality and significance. 2) The manuscript would benefit from a more explicit articulation of the theoretical framework underpinning the study. The authors should clearly outline how existing theories explain the influence of political ideology on public discourse, particularly in relation to health issues such as HIV. Drawing on relevant literature, the manuscript should specify the theoretical assumptions guiding the analysis and clearly state the main research question or hypotheses derived from this foundation. This would help to clarify the conceptual underpinnings of the study and establish a more coherent analytical framework. In addition to social representation theory, partisan theory should also be examined by the authors. Whether incorporated within the introduction or presented as a distinct section, a well-defined theoretical framework would not only enhance the study’s rigor but also position it more firmly within the broader academic discourse on political ideology and public health. 3) The study claims to employ both qualitative and quantitative analyses; however, it presents only qualitative analysis in the form of discourse analysis, with no clear evidence of quantitative analysis. The quantitative component should be explicitly defined, and the methodology and results clearly presented to ensure methodological coherence and transparency. 4) The Methods section would benefit from greater detail, particularly regarding the rationale for selecting Critical Discourse Analysis (CDA) as the primary methodological approach. The authors should clearly justify the choice of CDA over alternative methods, explaining how it aligns with the research objectives and is well-suited to analyzing the specific characteristics of parliamentary discourse. Additionally, the reliability and applicability of CDA in this context should be supported with appropriate references from the literature. A more robust explanation of the research design, including the methodological strengths and potential limitations of CDA, would enhance the study's transparency and rigor. 5) In the Discussion section, the authors are encouraged to compare and contrast their findings with those of previous studies in the field. This would help to contextualize the results, underscore the originality of the research, and clarify its contribution to the existing body of knowledge. 6) The conclusion section should be expanded to offer a more comprehensive analysis of the implications of the study’s findings. The authors should clearly articulate the study’s contributions to the existing literature and highlight its practical significance, particularly in relation to policymaking and public health discourse. Additionally, a critical reflection on the study’s limitations is recommended, along with suggestions for future research directions that could further explore the relationship between political ideology and health-related discourse. 7) The generalizability of the findings is limited to one regional context. Although this is acknowledged, a more explicit discussion of how these insights may or may not extend to national or other international legislative bodies would strengthen the paper. 8) The manuscript contains occasional grammatical errors and typographical mistakes, such as the repetition of 'in' in the phrase "in in this context" found in the abstract. ********** what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy Reviewer #1: No Reviewer #2: Yes: Prof. Dr. Rasim Yilmaz ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/ . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org . Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
From fear of infection to awareness against stigma: a mixed-methods analysis of discourses on HIV in a parliamentary context PONE-D-25-26592R1 Dear Dr. Sánchez, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. For questions related to billing, please contact billing support . If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Sylvester Chidi Chima, M.D., L.L.M, LD Academic Editor PLOS ONE Reviewers' comments: Reviewer's Responses to Questions Comments to the Author Reviewer #1: All comments have been addressed Reviewer #2: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions??> Reviewer #1: Yes Reviewer #2: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? -->?> Reviewer #1: Yes Reviewer #2: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available??> The PLOS Data policy Reviewer #1: Yes Reviewer #2: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English??> Reviewer #1: Yes Reviewer #2: Yes ********** Reviewer #1: All comments have been adequately addressed. Authors have paid attention to detail in the revised manuscript. Reviewer #2: All comments have been addressed. All required questions have been answered and that all responses meet formatting specifications. ********** what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy Reviewer #1: No Reviewer #2: Yes: Prof. Dr. Rasim Yilmaz ********** |
| Formally Accepted |
|
PONE-D-25-26592R1 PLOS ONE Dear Dr. Barba-Sánchez, I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team. At this stage, our production department will prepare your paper for publication. This includes ensuring the following: * All references, tables, and figures are properly cited * All relevant supporting information is included in the manuscript submission, * There are no issues that prevent the paper from being properly typeset You will receive further instructions from the production team, including instructions on how to review your proof when it is ready. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few days to review your paper and let you know the next and final steps. Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. You will receive an invoice from PLOS for your publication fee after your manuscript has reached the completed accept phase. If you receive an email requesting payment before acceptance or for any other service, this may be a phishing scheme. Learn how to identify phishing emails and protect your accounts at https://explore.plos.org/phishing. If we can help with anything else, please email us at customercare@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Professor Sylvester Chidi Chima Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .